This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Original Article -
Assessment of heme oxygenase-1 (HO-1) activity in the
cavernous tissues of sildenafil citrate-treated rats
M. Talaat Abdel Aziz1, M. Farid
Al-Asmar2, Taymour Mostafa3, Hazem
Atta1, Laila Rashed1, Dina
Sabry1, Shedeed Ashour3, Ahmed T. Abdel
Aziz1
1Molecular Biology Unit, Medical Biochemistry Department, Faculty of Medicine, Cairo University, Cairo 11553, Egypt
2Medical Biochemistry Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
3Andrology Department, Faculty of Medicine, Cairo University, Cairo 11553, Egypt
Abstract
Aim: To assess heme oxygenase-1 (HO-1) activity in the cavernous tissue of sildenafil citrate-treated rats.
Methods: One hundred and ninety-two Sprague-Dawley male rats, divided into four equal groups, were investigated. Group 1,
the control group, received regular animal chow; group 2 received sildenafil citrate by intragastric tube; group 3
received sildenafil and HO inhibitor (zinc protoporphyrin, ZnPP); and group 4 received sildenafil and nitric oxide
synthase (NOS) inhibitor L-nitroarginine methyl ester (L-NAME). Twelve rats from each group were killed after 0.5 h,
1 h, 2 h and 3 h of drug administration. Then HO-1 activity, cGMP levels and NOS enzymatic activity in the
cavernous tissues were estimated. Results:
In cavernous tissue, HO-1 activity, NOS enzymatic activity and cGMP
concentration increased significantly in sildenafil-treated rats compared to other groups throughout the experiment.
Rats receiving either HO or NOS inhibitors showed a significant decrease in these parameters. HO-1 cavernous tissue
activity and NOS enzymatic activity demonstrated a positive significant correlation with cGMP levels
(r = 0.646, r = 0.612 respectively;
P < 0.001). Conclusion: The actions of
PDE5 inhibitor sildenafil citrate in the cavernous tissue
are partly mediated through the interdependent relationship between both HO-1 and NOS activities.
(Asian J Androl 2007 May; 9: 377_381)
Keywords: erectile dysfunction; heme oxygenase; sildenafil citrate; nitric oxide synthase; carbon monoxide
Correspondence to: Prof. Taymour Mostafa, Andrology Department, Faculty of Medicine, Cairo University, Cairo 11553, Egypt.
Tel: +20-1051-50297 Fax: +20-2363-2297
E-mail: taymour1155@link.net
Received 2006-05-06 Accepted 2006-09-22
DOI: 10.1111/j.1745-7262.2007.00241.x
1 Introduction
Penile erection is reached through increased blood flow to the cavernous tissues, mediated by opening of penile
resistance vessels (helicine arteries), relaxation of cavernous tissue cells and occlusion of the venous outflow. This
erectile response is known to depend on nitric oxide (NO) released from nerves and vascular endothelium, activating
soluble guanylate cyclase (sGC) that increases the concentration of cGMP. cGMP functions as a signaling mediator
in the vasodilatation and the regulation of vascular tone. It activates cGMP-dependent protein kinase, which activates
the Ca2+/ATPase pump that extrudes
Ca2+ into the endoplasmic reticulum. It also activates the
Ca2+/K efflux pump that extrudes
Ca2+ across the plasma membrane. Consequently smooth muscle cell relaxation occurs as a result of
decreased intracellular Ca2+ [1].
Thus, erectile function is determined by tight regulation of relaxation or contraction of corpus cavernosal smooth
muscle, which is the result of a long and complex chain of molecular events. Control of erectile function resides in the
signaling pathways of the central and peripheral nervous
systems and in intracellular events in the penile smooth
muscle. This knowledge has led to the development and
current availability of effective oral treatments for
erectile dysfunction, including the selective phosphodiesterase
type 5 (PDE5) inhibitors [2].
Sildenafil citrate was the first introduced
PDE5 inhibitors. Since its launch in 1998, it has proven
effective in the treatment of male erectile dysfunction.
Besides its proved erectogenic action it has demonstrated
different beneficial, non-erectogenic actions. Sildenafil
had been useful in the management of pulmonary hypertension, female sexual dysfunction, enhanced
female genital blood flow and endometrial thickening.
Sildenafil also exerts several effects that are of clinical
relevance in gastrointestinal disorders. In patients with
heart failure, the PDE5 inhibitor
improved the capacity for exercise in endothelial dysfunction. Moreover, in the
treatment of Raynaud's phenomenon, a disease that as yet has
no highly effective medical treatment, sildenafil has some
has shown some promise [3].
Heme oxygenase (HO) enzyme catalyzes the rate
limiting step in oxidative degradation of heme to biliverdin,
releasing equimolar amounts of carbon monoxide (CO)
and iron. Two isoforms of HO exist as products of
distinct genes. HO-1 is an inducible isoform distributed in
the mammalian tissues and HO-2 is constitutively expressed, predominantly found in the central nervous
system [4]. The relationship between the CO/HO
system and NO/NOS system is controversial. While some
studies reported synergism between NO and CO [5], others reported that inhibition of NO synthesis promoted
renal production of CO [6]. Abdel-Aziz et
al. [7] indicated that the induction of NOS or HO is equally
effective in enhancing erectile function via the upregulation of
their gene expression and the local tissue levels of cGMP,
the mediator of vasodilatation.
The aim of the present work is to assess HO-1
activity in the cavernous tissue of sildenafil citrate-treated
rats.
2 Materials and methods
2.1 Animals
One hundred and ninety-two Sprague-Dawley male rats (weight range 130_150 g) were used in this work.
They were bred in the animal house at the Faculty of
Medicine, Cairo University Hospital according to NIH
guidelines. They were divided into four equal groups.
Group 1, the control group, received regular animal chow;
group 2, received the same diet in addition to sildenafil
citrate (4 mg/kg bodyweight) through a gastric tube
(equivalent to 50 mg dose adjusted according to Paget's
table of experimental studies) [8]; group 3 received
sildenafil citrate and HO inhibitor (zinc protoporphyrin,
ZnPP; 50 µg/kg); and group 4 received the same dose of
sildenafil citrate and NOS inhibitor L-nitroarginine
methylester (L-NAME; 250 mg/kg).
2.2 Samples
The rats were killed in groups of twelve by cervical
dislocation after 0.5, 1, 2 and 3 h. Cavernous penile tissues
were dissected and divided into two portions. The first
was put in homogenization buffer to estimate HO enzyme
activity. The buffer contained sucrose (0.25 mol/L), 0.1
mol/L KCl, 1 mmol/L Tris HCl and 0.4 mol/L phenyl
methyl sulfonyl fluoride (PMSF), adjusted to pH 7.8. The
second portion was kept in 0.1 mol/L HCl to inhibit
phosphodiesterase enzyme, stored at
_80oC and used for cGMP assay by ELISA.
2.3 cGMP assay
Cavernous tissue samples stored in 0.1 mol/L HCl
were homogenized and centrifuged at 6 000 ×
g, at 4ºC for 10 min. The supernatant was used for cGMP assay
by ELISA kit (R&D Systems, Minneapolis, MN, USA).
2.4 HO-1 enzyme activity assay
Cavernous tissue homogenized samples were incubated in medium consisting of heme (50 µmol/L), rat
liver cytosol (5 mg/mL), MgCl2 (2 mmol/L),
glucose-6-phosphate dehydrogenase (1 unit), glucose-6-phosphate
(2 mmol/L) and NADPH (0.8 mmol/L) in 0.5 mL of 0.1
mol/L phosphate buffer saline (pH 7.4) for 60 min at
37ºC. Reaction was stopped by cooling the tubes on
crushed ice and then the bilirubin product was extracted
with chloroform. The concentration of bilirubin was
monitored at 464 nm and 520 nm by a spectrophotometer and was then calculated by using an extinction
coefficient of 40.0 mmol/L [9].
2.4 NOS enzymatic activity
Nitrite and nitrate were used as markers for assay of
the activity of NOS. Nitrite was measured by using the
Griess reaction, the griess reagent (1 g/L sulfanilamide ,
25 g/L phosphoric acid and 0.1 g/L
N-1-naphthylethylenediamine ) was added to the homogenized cavernous
tissue samples. After 10 min of color development at
room temperature, the absorbance was measured at 543
nm. Nitrate was measured as nitrite after enzymatic
conversion by nitrate reductase [10].
2.5 Statistical analysis
Numerical data were expressed as mean ± SD and
range. Comparisons were performed by one-way ANOVA
test. Correlations were tested by Spearman's test.
Comparisons and correlations were considered statistically
significant if P < 0.05.
3 Results
Cavernous tissues HO-1 activity (pmol bilirubin/mg
protein/min) was significantly higher in the sildenafil-
treated group compared to other groups, where it reached
a peak 1 h after administration, and then dropped
gradually for 3 h but remained higher than the control levels.
In rats that received sildenafil added to either HO (group
3) or NOS inhibitors (group 4) exhibited equally
significant decreases in HO activity compared to groups 1 and
2 (Figure 1). NOS enzymatic activity (µmol/mg protein)
in the cavernous tissues was also significantly higher in
sildenafil citrate-treated groups compared to all other
groups. Rats that received sildenafil added to the NOS
inhibitor demonstrated significant decreases compared
to those that received either sildenafil or sildenafil added
to the HO inhibitor (Figure 2). cGMP levels (pmol/mg)
in cavernous tissue were also significantly higher in
sildenafil citrate-treated groups compared to all other
groups. Rats that received sildenafil added to the NOS
inhibitor demonstrated a significant decrease in cGMP
levels compared to those that either received sildenafil or
sildenafil added to the HO inhibitor (Figure 3).
Cavernous tissue HO-1 activity demonstrated a positive
significant correlation with cGMP levels and NOS enzymatic
activity in all groups (r = 0.646, r = 0.612;
P < 0.001).
4 Discussion
Clinical studies have demonstrated that sildenafil
citrate successfully treats erectile dysfunction of varied
etiologies. The impact of sildenafil has stimulated
academic, clinical and industrial researchers to conduct
experiments aimed at understanding the mechanism(s)
underlying erectile function, hoping to develop better
treatment modalities. PDE5 is the major cGMP
hydrolyzing enzyme in the penile cavernous tissues and is an
important regulator of NO-mediated smooth-muscle
relaxation [11]. NO is formed from oxidation of
L-arginine by NOS isoforms: neuronal (nNOS), endothelial
(eNOS) and inducible (iNOS). NO plays a crucial role in
initiating and maintaining an increase in intracavernous
pressure, penile vasodilatation and penile
erection-dependent cGMP [12].
In the present work, HO-1 and NOS enzymatic cavernous tissue activities were significantly higher in the
sildenafil-treated group, compared to the controls after
one half hour and reached a peak after 1 h. A gradual
drop was observed after that and this continued for 3 h.
However, it was always higher than that of the controls.
These activities in rats treated with the same dose of
sildenafil citrate added to either HO or NOS inhibitors
exhibited a dramatic decline of these activities, and reached
levels even below that of the controls. Meanwhile,
cavernous tissue cGMP level coincided with HO-1 and NOS
activity changes; significantly increased in the
sildenafil-treated group compared to the controls after one half an
hour with a peak after 1 h, followed by a gradual decline
for 3 h. This finding was supported by demonstrating a
positive correlation between HO-1, NOS activities and
cGMP levels in the investigated cavernous tissues. NOS
inhibitor showed a stronger influence in declining c-GMP
than HO inhibitor when added to sildenafil-treated rats.
Based on these data, the increase of HO-1 activity by
sildenafil citrate is mainly an indirect effect of NO, not
sildenafil citrate. This new and important observation
could point to the signaling mode of action(s) taking place
in this process. These results were in agreement with
Vidavalur et al. [13] who reported that human coronary
arteriolar endothelial cells exposed to sildenafil
demonstrated significant induction of HO-1 enzyme activity.
In addition, Bivalacqua et al. [14] reported sildenafil
significantly increased expression levels of eNOS and cGMP
in streptozitocine (STZ) treated rats and that the erectile
response was greater in STZ-diabetic rats receiving eNOS
gene therapy plus sildenafil than STZ-diabetic rats
receiving either sildenafil or eNOS gene therapy alone.
sGC is a heme-dependent enzyme that catalyzes the
formation of guanosine 3',5'-cGMP after the binding of
NO to the iron of the heme group. The purified
heme-containing form of sGC has also been reported to be
activated by CO. Endogenously produced CO has been
shown to possess intriguing signaling properties
affecting numerous critical cellular functions including but not
limited to inflammation, cellular proliferation, and
apoptotic cell death. The discovery that endogenously
produced gaseous molecules such as NO and CO can exert potent physiological and biological effecter
functions truly represented a paradigm shift and unraveled
new avenues of intense investigations [15]. CO exhibits
physiological properties similar to NO and it is believed
that these actions are mediated in part by the ability of
CO to act as an activator of sGC. Like NO, CO binds to
the heme moiety of sGC leading to its activation and an
increase in cGMP levels. After the induction of HO-1 in
the rat aorta, the tissue cGMP content was greatly
enhanced and was believed to be a part of the mechanism
that underlies CO vasodilator activity [16].
Abdel-Aziz et al. [7] indicated that induction of
either NOS (using L-arginine) or HO (using hemin) was
equally effective in enhancing erectile function via the
upregulation of gene expression of the two signaling
molecules, NOS and HO-1, and through concomitant upregulation of the local tissue levels of cGMP. Hedlund
et al. [17] found that the cholinergic nerve terminals in
the human corpora cavernosa and corpus spongiosum contain NOS, HO-1 and HO-2 genes and enzymes,
suggesting that these terminals comprise a distinct
population of parasympathetic cholinergic nerves and that
HO/CO systems have a complimentary role in
erection [18]. The role of CO as an NO-like signaling molecule is also
supported in studies of HO and NOS knockouts. Furthermore, both HO-1- and HO-2-derived CO have a
positive and negative effect on sGC and cGMP levels in
vascular endothelial cells [19]. Nevertheless, the
CO-releasing molecule CORM-3 has been shown to have a
potent vasodilator effect in normal and diabetic rats [20].
Also, HO-1 overexpression increased vascular relaxation
and NO bioavailability [21]. Ryter
et al. [5] stated that HO protects NO through the scavenging of reactive
oxygen species (ROS). Thus, HO prevents NO from
reacting with ROS, preventing the formation of peroxynitrite
and its subsequent degradation, confirming that CO
tissue levels parallel NO levels.
It is concluded that the actions of the
PDE5, sildenafil citrate, in the cavernous tissue are partly mediated through
the interdependent relationship between HO-1 and NOS
activities and the upregulation of the tissue levels of
cGMP, the mediator of vasodilatation.
References
1 Hellstrom WJ. The molecular basis of erectile physiology:
From bench to bedside. J Androl 2002; 23: S3_4.
2 Seftel AD. Phosphodiesterase type 5 inhibitors: molecular
pharmacology and interactions with other phosphodiesterases.
Curr Pharm Des 2005; 11: 4047_58.
3 Cremers B, Bohm M. Non erectile dysfunction application of
sildenafil. Herz 2003; 28: 325 _33.
4 Wang J, Lu S, Moenne P, Montellano OR. Interaction of nitric
oxide with human heme oxygenase-1. J Biol Chem 2003; 278:
2341_7.
5 Ryter SW, Morse D, Choi AM. Carbon monoxide: to boldly
go where nitric oxide has gone before. Sci STKE 2004; 2004
(230): RE6.
6 Rodriguez F, Lamson BD, Gong W, Kemp R, Nasjletti A.
Nitric oxide synthesis inhibition promotes renal production of
carbon monoxide. Hypertension 2004; 43: 347_51.
7 Abdel-Aziz MT, El-Asmar MF, Mostafa T, Atta H, Abdel
aziz M, Fouad H, et al. Effects of nitric oxide synthase and
heme oxygenase inducers and inhibitors on molecular signaling
of erectile function. Clin Biochem Nut (Japan) 2005; 37:
103_11.
8 Paget GE, Barnes GM. Evaluation of Drug Activities. Vol. 1,
Academic Press: London. 1964.
9 Abraham NG, Lutton JD, Levere RD. Heme metabolism and
erythropoiesis in abnormal iron states. Role of aminolevulinic
acid synthetase and heme oxygenase. Exp Haemato 1985; 13:
833_43.
10 Moshag H, Kok B, Huizenga JR, Jansen LM. Nitrite and
nitrate determination in plasma: A critical evaluation. Clin
Chem 1995; 41: 892_6
11 Jackson G, Gillies H, Osterloh I. Past, present and future: a
7-year update of Viagra (sildenafil citrate). Int J Clin Pract 2005;
59: 680_91.
12 Toda N, Ayajiki K, Okamura T. Nitric oxide and penile function.
Pharmacol Ther 2005; 106: 233_66.
13 Vidavalur R, Penumathsa SV, Zhan L, Thirunavukkarasu M,
Maulik N. Sildenafil induces angiogenic response in human
coronary arteriolar endothelial cells through the expression of
thioredoxin, hemeoxygenase and vascular endothelial growth
factor. Vascul Pharmacol 2006; 19; 45: 91_5.
14 Bivalacqua TJ, Usta MF, Champion HC, Leungwattanakij S,
Dabisch PA, McNamara DB, et al. Effect of combination
endothelial nitric oxide synthase gene therapy and sildenafil
on erectile function in diabetic rats. Int J Impot Res 2004; 16:
21_9.
15 Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon
monoxide: from basic science to therapeutic applications.
Physiol Rev 2006; 86: 583_650.
16 Wang R, Wang Z, Wu L. Carbon monoxide-induced
vasorelaxation and the underlying mechanisms. Br J Pharmacol
1987; 121: 927_34.
17 Hedlund P, Ny L, Anderson KE. Cholinergic nerves in human
corpus cavernosum and spongiosum contain nitric oxide
synthase and heme oxygenase. J Urol 2000; 164: 868_75.
18 Wang J, Lu S, Moenne P, Montellano OR. Interaction of nitric
oxide with human heme oxygenase-1. J Biol Chem 2003; 278:
2341_7.
19 Abraham NG, Quan S, Mieyal PA, Yang L, Burke-Wolin T,
Mingone CJ, et al. Modulation of cGMP by human HO-1
retrovirus gene transfer in pulmonary microvessel endothelial
cells. Am J Physiol Lung Cell Mol Physiol 2002; 282:
L1117_24.
20 Di Pascoli M, Rodella L, Sacerdoti D, Bolognesi M, Turkseven
S, Abraham NG. Chronic CO level has a beneficial effect on
vascular relaxation in diabetes. Biochem Biophys Res Commun
2005; 340: 935_43.
21 Ahmad M, Turkseven S, Mingone CJ, Gupte SA, Wolin MS,
Abraham NG. Heme oxygenase-1 gene expression increases
vascular relaxation and decreases inducible nitric oxide
synthase in diabetic rats. Cell Mol Biol 2005; 51: 371_6. |